Originally published in the NAVBO NewsBEAT or NAVBO Newsletter
Kazuyo Kegan (from the July 6 NewsBEAT)
Kazuyo Kegan, PhD, Assistant Professor in the Department of Anesthesiology and Critical Care Medicine at Johns Hopkins University, School of Medicine, recently received a Proof of Concept grant from the American Thoracic Society (ATS)/Pulmonary Hypertension Association (PHA). The grant's target audience is investigators who are interested in early-stage pulmonary hypertension research. Read more about Dr. Kegan's award at https://phassociation.org/research/pharesearchprogram/proof-of-concept/proof-of-concept-winners/
Visit Dr. Kegan's web page at http://www.hopkinsmedicine.org/profiles/results/directory/profile/3020428/kazuyo-yamaji-kegan
Ralf Adams (from the June 8 NewsBEAT)
The European Society for Microcirculation (ESM) presented Dr. Ralf Adams with its 2017 Malpighi Award, given in recognition of Dr. Adams's outstanding international reputation in microcirculation research. Professor Adams, of the Department of Tissue Morphogenesis in the Max Planck Institute for Molecular Biomedicine and member of the Faculty of Medicine at the University of Münster, received the Malpighi Award medal at the ESM-EVBO 2017 Conference in Geneva, Switzerland, May 29-June 1, 2017. Congratulations, Dr. Adams!
Visit Dr. Adams's web page at http://www.mpi-muenster.mpg.de/96841/adams
Kari Alitalo (from the May 25 NewsBEAT)
The research of Dr. Kari Alitalo, Academy Professor in the Translational Cancer Biology Research Program at the University of Helsinki and one of the principal organizers of IVBM 2018, was prominently featured in a recent article in The Washington Post. The Post report explores implications of Dr. Alitalo's finding, together with Swiss and Norwegian collaborators, of evidence for an organized lymphatic system serving the brain. The description of lymphatic vessels by Dr. Alitalo and other scientists working independently in the U.S. has opened new avenues for exploring mechanisms of Alzheimer's, Huntington's, and Parkinson's Diseases, as well as other neurodegenerative and autoimmune disorders.
Visit Dr. Alitalo's web page at http://research.med.helsinki.fi/cancerbio/alitalo/index.html
Mark Kahn (from the May 11 NewsBEAT)
Studies published in Nature by Mark Kahn and fellow researchers at the University of Pennsylvania, the Universities of Chicago, Utah, New Mexico, and California-San Francisco, and international collaborators in Australia, China, the Netherlands, Germany, and Sweden, were featured in a May 10 New York Times Health column by Gina Kolata. Dr. Kahn has been a NAVBO member since 2007, serving the organization as a member of the Meritorious Awards Committee, speaker at countless meetings and recipient of the Judah Folkman Award in 2013. The new studies identify activation of endothelial Toll-like receptor 4 by Gram-negative bacteria as a critical event in formation of cerebral cavernous malformations, a significant predisposing condition for stroke and seizure for which effective medical therapies are lacking. This finding reveals unexpected roles for the microbiome and innate immune signalling in the pathogenesis of a cerebrovascular disease, as well as suggesting novel strategies for its treatment.
Visit Dr. Kahn's web page at http://www.med.upenn.edu/kahnlab/
Klaus Ley (from the April 27 NewsBEAT)
Klaus Ley, M.D., has been selected as the 2017 winner of the Microcirculatory Society's Eugene M. Landis Award, in recognition of his pioneering work in vascular biology and the microcirculation. Dr. Ley presented the Landis Award Lecture on Leukocyte Integrin Activation on April 23, 2017, during the MCS Annual Meeting at Experimental Biology in Chicago. Dr. Ley has been a NAVBO member since 2005, serving the organization as President (2013-14), Secretary-Treasurer (2011-12), Chair of the Meritorious Awards Committee (2010-13), and Member of the Development Committee (2013-15); he organized the 2013 Vasculata and the 2014 Vascular Inflammation Workshop. Trained in medicine at the Julius-Maximilians-Universität, Würzburg, Germany, Dr. Ley was a postdoctoral researcher at the Freie Universität Berlin, to which he returned to after a short stint as a visiting research scientist at the University of California, San Diego. He joined the faculty of the University of Virginia in 1994, serving as director of the Robert M. Berne Cardiovascular Research Center from 2001 until 2007. He joined La Jolla Institute for Allergy and Immunology as Professor and founding Head of the Division of Inflammation Biology in 2007. Congratulations, Dr. Ley - NAVBO celebrates your achievement!
Visit Dr. Ley's web page at http://www.lji.org/faculty-research/labs/ley/#overview
Brant Weinstein (from the April 13 NewsBEAT)
The research of Dr. Brant Weinstein, Senior Investigator at the NICHD and organizer of numerous NAVBO workshops, is featured in a recent news release from the NIH. Dr. Weinstein and his colleagues in the Section on Vertebrate Organogenesis have published in eLIFE findings in zebrafish that implicate a novel family of perivascular cells in creation and maintenance of the blood-brain barrier. Intriguingly, these cells, which resemble perivascular macrophages or so-called 'Mato Cells' in mammals, appear to emerge by transdifferentiation from endothelium of the optic choroidal vascular plexus, and as such would represent the first described perivascular cell population in the brain derived from vascular endothelium.
Visit Dr. Weinstein's web page at http://uvo.nichd.nih.gov/